Niagen Bioscience (NAGE) Finished Goods (2018 - 2019)
Niagen Bioscience (NAGE) reported Finished Goods of $4.9 million for Q4 2019, up 99.06% year-over-year from $2.4 million in Q4 2018, and up 99.06% quarter-over-quarter from $2.4 million in Q4 2018.
Niagen Bioscience (NAGE) Finished Goods (2018 - 2019) Analysis & Trends
Niagen Bioscience (NAGE) has 2 years of Finished Goods data on file, last reported at $4.9 million in Q4 2019.
- Finished Goods for Q4 2019 came in at $4.9 million, up 99.06% year-over-year; the trailing twelve-month figure through Dec 2019 was $4.9 million (up 99.06% YoY), and the FY2019 annual result was $4.9 million, up 99.06% from the prior year.
- Finished Goods advanced to $4.9 million in Q4 2019 per NAGE's latest filing, from $2.4 million in the prior quarter.
- Over five years, Finished Goods peaked at $4.9 million in Q4 2019 and troughed at $2.4 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Niagen Bioscience | 280.11 Mn | 213.56 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 4.88 Mn |
| Dec 31, 2018 | 2.45 Mn |